Study on Multiple Drug Trials for Children and Young Adults with Cancer
Sponsor: Eli Lilly and Company
ClinicalTrials ID:NCT05999994
This clinical trial program is designed to test various drugs for treating cancer in children and young adults. It aims to streamline the research process by using a common protocol for multiple studies, with new trials added as new drugs become available.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The purpose of this study is to efficiently conduct multiple clinical trials for different cancer drugs in children and young adults. Each trial under this program will focus on specific drugs and cancer types. New trials will be introduced as new drugs are developed. Participation in the study will continue as long as the treatment benefits the participant.
Eligibility Criteria
Inclusion Criteria
- Have cancer that can be measured or evaluated using standard medical techniques.
- Have a performance score of at least 50, which measures general well-being and ability to carry out daily activities.
- Must have stopped all previous cancer treatments at least 7 days before starting the trial and recovered from any significant side effects.
- Have good blood and organ function.
- Female participants who can become pregnant must have a negative pregnancy test within 7 days before starting the trial.
- Both male and female participants who can have children must agree to use effective birth control during the trial and for at least 3 months after the last dose of the study drug.
Exclusion Criteria
- Have severe or uncontrolled medical or psychiatric conditions that could pose safety risks or affect participation in the trial.
- Have active infections that require treatment.
- Have had a bone marrow or organ transplant.
- Have had or plan to have certain invasive medical procedures.
- Female participants who are pregnant or breastfeeding.
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.